A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment.

A new interesting article has been published in J Med Microbiol. 2019 Dec; 68(12):1766-1770. doi: 10.1099/jmm.0.001109. and titled: A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment. Authors of…

Continue ReadingA positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment.